These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 15751713)

  • 21. [The effect of leukinferon on the invasive process in experimental helminthiases].
    Malysheva NS; Shuĭkina EE; Lebedeva MN; Fedianina LV
    Med Parazitol (Mosk); 1998; (1):17-20. PubMed ID: 9608203
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Interferon therapy of acute pneumonia in infants].
    Spivak NIa; Moshchich PS; Tarinskaia OL; Ganova LA; Krivokhatskaia LD
    Antibiot Khimioter; 1993 Jul; 38(7):40-3. PubMed ID: 8161277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Immunoprophylaxis of postoperative inflammatory complications in thoracic and abdominal wounds].
    Bulava GV; Abakumov MM; Danielian ShN; Nikulina VP; Khvatov VB
    Khirurgiia (Mosk); 2002; (7):4-10. PubMed ID: 12162084
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [The use of a complex preparation of alpha-interferon and first-phase immune-response cytokines--leukinferon].
    Gruzdeva TA; Kuznetsov VP; Beliaev DL; Vakhman IS; Fedorova NV; Babaiants AA; Polikarpova EV
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (1):59-64. PubMed ID: 8184616
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The effect of treatment on the course of invasion by Hymenolepis nana and the state of its population in white mice].
    Malysheva NS
    Med Parazitol (Mosk); 1998; (2):46-8. PubMed ID: 9691622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [The clinico-immunological effects of leukinferon in the treatment of patients with acute suppurative pyelonephritis].
    Vozianov AF; Kuznetsov VP; Driianskaia VE; Pasechnikov SP; Ozvinchuk II; Fedoruk GV; Drannik GN
    Lik Sprava; 1997; (1):88-92. PubMed ID: 9221157
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The clinical efficacy in using leukinferon in adults with diseases caused by the varicella-zoster virus].
    Kuznetsov VP; Nikolaeva IN; Barer GM; Beliaev DL; Sundukov AV; Babaiants AA; Iushchuk ND
    Zh Mikrobiol Epidemiol Immunobiol; 1995; (4):72-5. PubMed ID: 9381878
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Combined detoxification and immunocorrective therapy in patients with peritonitis].
    Shkrob LO; Fedotov PA; Ermakova NG
    Khirurgiia (Mosk); 1994 Mar; (3):20-2. PubMed ID: 8007606
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunomodulating properties of leukinferon].
    Iushchuk ND; Zmyzgova AV; Tugutova IV; Kuznetsov VP; Babaiants AA; Novikova TA; Eremina OF; Mesniankin AP; Lebedev VV; V'iushina MA
    Sov Med; 1990; (7):11-4. PubMed ID: 2251550
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Use of cytokines in the complex treatment of respiratory diseases].
    Gel'tser BI; Prosekova EV; Kondrashova NM
    Klin Med (Mosk); 2004; 82(9):13-9. PubMed ID: 15540415
    [No Abstract]   [Full Text] [Related]  

  • 31. The efficiency of chemotherapy with immunomodulators for patients with destructive lung tuberculosis.
    Khomenko AG; Insanov AB
    Z Erkr Atmungsorgane; 1986; 167(1-2):163-7. PubMed ID: 3765712
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Efficiency of immunocorrection using cytokines in the therapy of papillomavirus infection].
    Dubenskiĭ VV; Kuznetsov VP; Beliaev DL; Sliusar' NN
    Zh Mikrobiol Epidemiol Immunobiol; 2001; (5):54-8. PubMed ID: 11871303
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Leukinferon in the treatment of patients with sepsis and multiple organ dysfunction syndrome].
    Kuznetsov VP; Markelova EV; Smirnov GA; Lazanovich VA; Beliaev DL
    Antibiot Khimioter; 2002; 47(5):3-7. PubMed ID: 12365325
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Secondary immunodeficiency and its myelopid correction in patients with infiltrative and disseminated pulmonary tuberculosis].
    Averchenkov VM; Lomachenkov VD; Fedotova NI; Meshkova RIa
    Probl Tuberk; 1998; (2):20-2. PubMed ID: 9613178
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Effects of interferon preparations on the course of Salmonella infection (experimental and clinical studies)].
    Spivak NIa; Fil'chakov IV; Treshchinskiĭ AI; Kuznetsov VP; Zaritskiĭ AM; Belotskiĭ SM
    Antibiot Khimioter; 1992 Mar; 37(3):28-31. PubMed ID: 1514865
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [The effect of indomethacin and leukinferon on the thromboxane B2 level in the blood plasma of patients with endometrial cancer in the perioperative period].
    Bassalyk LS; Shoshiashvili VD; Kushlinskiĭ NE; Mistakopulo NF; Kuznetsov VP; Rylov VV; Liakina LT
    Vopr Onkol; 1992; 38(5):555-61. PubMed ID: 1300754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [The interferon reaction of the leukocytes and the natural killer activity in patients with acute viral hepatitis B undergoing interferon treatment].
    Golban TD; Cheshik SG; Kuznetsov VP; Beliaev DL; Grishchenko SV; Morgunov KM; Babaiants AA; Polikushina OE; Antonenko SM
    Vopr Virusol; 1994; 39(4):177-9. PubMed ID: 7998397
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Levamisole and diucifon immunochemotherapy of chronic destructive pulmonary tuberculosis].
    Khomenko AG; Insanov AB
    Probl Tuberk; 1984 Sep; (9):23-7. PubMed ID: 6504881
    [No Abstract]   [Full Text] [Related]  

  • 39. [The use of leukinferon in treating zoonotic cutaneous leishmaniasis. 2. Patient treatment].
    Sergiev VP; Shuĭkina EE; Kuznetsov VP; Beliaev DL; Fediainova IE; Norbadalov MT; Suntsov SN
    Med Parazitol (Mosk); 1993; (1):42-3. PubMed ID: 8336652
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of thymogen on the state of immunity in destructive pulmonary tuberculosis].
    Medus AI; Pisarevskaia LI; Nikishina EV
    Voen Med Zh; 1999 Oct; 320(10):65-7, 96. PubMed ID: 10605346
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.